These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38868897)

  • 1. The Role of Interleukin-22 in Controlling Virus Infections at Mucosal Surfaces.
    Guo C; Boulant S; Stanifer ML
    J Interferon Cytokine Res; 2024 Aug; 44(8):349-354. PubMed ID: 38868897
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudorabies virus-induced expression and antiviral activity of type I or type III interferon depend on the type of infected epithelial cell.
    Yin Y; Ma J; Van Waesberghe C; Devriendt B; Favoreel HW
    Front Immunol; 2022; 13():1016982. PubMed ID: 36405751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces.
    Stanifer ML; Guo C; Doldan P; Boulant S
    Front Immunol; 2020; 11():608645. PubMed ID: 33362795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpesviruses and the Type III Interferon System.
    Yin Y; Favoreel HW
    Virol Sin; 2021 Aug; 36(4):577-587. PubMed ID: 33400088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.
    Pervolaraki K; Stanifer ML; Münchau S; Renn LA; Albrecht D; Kurzhals S; Senís E; Grimm D; Schröder-Braunstein J; Rabin RL; Boulant S
    Front Immunol; 2017; 8():459. PubMed ID: 28484457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells.
    Doldan P; Dai J; Metz-Zumaran C; Patton JT; Stanifer ML; Boulant S
    J Virol; 2022 Sep; 96(17):e0070622. PubMed ID: 36000839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
    J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential signaling by type-I and type-III interferons in mucosa.
    Stanifer ML; Boulant S
    Curr Opin Immunol; 2024 Feb; 86():102400. PubMed ID: 38118395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon Lambda Genetics and Biology in Regulation of Viral Control.
    Hemann EA; Gale M; Savan R
    Front Immunol; 2017; 8():1707. PubMed ID: 29270173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic Differences and Synergistic Antiviral Effects Between Type I and Type III Interferon Signaling Indicate Pathway Independence.
    Voigt EA; Yin J
    J Interferon Cytokine Res; 2015 Sep; 35(9):734-47. PubMed ID: 25938799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
    Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
    J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of Type III Interferon (IFN) Genes
    Peterson ST; Kennedy EA; Brigleb PH; Taylor GM; Urbanek K; Bricker TL; Lee S; Shin H; Dermody TS; Boon ACM; Baldridge MT
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III IFNs: new layers of complexity in innate antiviral immunity.
    Ank N; Paludan SR
    Biofactors; 2009; 35(1):82-7. PubMed ID: 19319850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III Interferon Restriction by Porcine Epidemic Diarrhea Virus and the Role of Viral Protein nsp1 in IRF1 Signaling.
    Zhang Q; Ke H; Blikslager A; Fujita T; Yoo D
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus.
    Huang J; Smirnov SV; Lewis-Antes A; Balan M; Li W; Tang S; Silke GV; Pütz MM; Smith GL; Kotenko SV
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9822-7. PubMed ID: 17517620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation.
    Eberle KC; McGill JL; Reinhardt TA; Sacco RE
    J Virol; 2015 Dec; 90(6):2948-58. PubMed ID: 26719274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of type I interferons and interleukins 29 and 28a (type III interferons) against Apeu virus.
    Almeida GM; de Oliveira DB; Magalhães CL; Bonjardim CA; Ferreira PC; Kroon EG
    Antiviral Res; 2008 Dec; 80(3):302-8. PubMed ID: 18657576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.
    Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z
    Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.